Academic journal article Bulletin of the World Health Organization

Substandard and Falsified Medicines

Academic journal article Bulletin of the World Health Organization

Substandard and Falsified Medicines

Article excerpt

WHO Director-General Dr Tedros Adhanom Ghebreyesus called on countries to step up their efforts to tackle the problem of substandard and falsified medicines, since quality medicines are essential for achieving universal health coverage.

An estimated 1 in 10 medical (10%) products in low- and middle-income countries is either substandard or falsified, according to a new WHO study.

The study, Public health and socioeconomic impact of substandard and falsified medical products, published on 28 November 2017, reviewed more than 100 articles on medicine quality surveys in 88 low- and middle-income countries involving 48 000 samples.

Based on the 10% estimate, a modelling exercise by the University of Edinburgh in Scotland calculated that between 72 000 and 169 000 children maybe dying each year from pneumonia due to substandard and falsified antibiotics.

A second study by researchers from the London School of Hygiene and Tropical Medicine estimated that substandard and falsified medicines, could be a factor in 116 000 malaria deaths in sub-Saharan Africa. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.